adverse events

You have access
Analysis of 1027 Adverse Events Reports for Interspinous Process Devices From the US Food and Drug Administration Manufacturer and User Facility Device Experience Database
Gregory S. Kazarian, Yusef J. Jordan, Mitchell Johnson, Satyaj Bhargava, Robert Cecere, Takashi Hirase, Sheeraz Qureshi, James Dowdell, Evan Sheha, Francis Lovecchio and Sravisht Iyer

International Journal of Spine Surgery December 2024, 18 (6) 667-675; DOI: https://doi.org/10.14444/8652
You have access
Revision Spinal Surgery at a University Hospital: Incidence, Causes, and Microbiological Agents in Infected Patients
Pontus Dymén, Olof Westin, Adad Baranto and Annette Erichsen Andersson

International Journal of Spine Surgery October 2022, 16 (5) 928-934; DOI: https://doi.org/10.14444/8349
You have access
Modifiable Patient Factors Demonstrate No Increased Risk for 30-Day Complication Rate for Elective 1-2 Level Posterior Lumbar Fusion Surgery: A Comparison Between a National Database and Local Registry
Cameron Kia, Aris Yannopoulos, Sagar Gulati, Michael Cremins, Mark Cote and Isaac Moss

International Journal of Spine Surgery August 2022, 16 (4) 727-734; DOI: https://doi.org/10.14444/8296
You have access
Adverse Events Following Posterior Lumbar Fusion: A Comparison of Spine Surgeons Perceptions and Reported Data for Rates and Risk Factors
NATHANIEL T. ONDECK, DANIEL D. BOHL, PATAWUT BOVONRATWET, RYAN P. MCLYNN, JONATHAN J. CUI, ANDRE M. SAMUEL, MATTHEW L. WEBB and JONATHAN N. GRAUER

International Journal of Spine Surgery October 2018, 12 (5) 603-610; DOI: https://doi.org/10.14444/5074
You have access
Long-Term Clinical Experience with Selectively Constrained SECURE-C Cervical Artificial Disc for 1-Level Cervical Disc Disease: Results from Seven-Year Follow-Up of a Prospective, Randomized, Controlled Investigational Device Exemption Clinical Trial
ALEXANDER VACCARO, WILLIAM BEUTLER, WALTER PEPPELMAN, JOSEPH MARZLUFF, ANDREW MUGGLIN, PREM S. RAMAKRISHNAN, JACQUELINE MYER and KELLY J. BAKER

International Journal of Spine Surgery June 2018, 12 (3) 377-387; DOI: https://doi.org/10.14444/5044
Open Access
The First 18 Months Following Food and Drug Administration Approval of Lumbar Total Disc Replacement in the United States: Reported Adverse Events Outside an Investigational Device Exemption Study Environment
Scott L. Blumenthal, Richard D. Guyer, Fred H. Geisler, Paul C. McAfee and John J. Regan

International Journal of Spine Surgery January 2007, 1 (1) 8-11; DOI: https://doi.org/10.1016/SASJ-2006-0001-RR

Main menu

User menu

Search

adverse events

Content

More Information

More

Other Services